Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s13139-021-00695-6
Abstract: Tumour-induced osteomalacia is a rare paraneoplastic syndrome that manifests as chronic hypophosphataemia, non-specific bone pain and muscle weakness. It is generally caused by phosphaturic mesenchymal tumour (PMT), which is uncommonly associated with synchronous tumours. However,…
read more here.
Keywords:
extended whole;
dotatate pet;
disease;
induced osteomalacia ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Scientific Reports"
DOI: 10.1038/srep45395
Abstract: Tumour-induced dendritic cell (DC) dysfunction plays an important role in cancer immune escape. However, the underlying mechanisms are not yet fully understood, reflecting the lack of appropriate experimental models both in vivo and in vitro.…
read more here.
Keywords:
stat3 simultaneously;
stat3 signalling;
lung cancer;
cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Japanese journal of clinical oncology"
DOI: 10.1093/jjco/hyad180
Abstract: BACKGROUND extended curettage is generally used to treat infiltrative bone tumours. However, the extent of the curettage performed in previous studies remains unclear. This study aimed to investigate the efficacy of extended curettage for bone…
read more here.
Keywords:
curettage;
tumour induced;
bone;
induced osteomalacia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "BMJ Case Reports"
DOI: 10.1136/bcr-2016-218637
Abstract: Tumour-induced osteomalacia is a paraneoplastic syndrome wherein bone is affected by a hormone from a tumour that causes renal phosphate wasting and hypophosphataemia. Here, we present the case of a 31-year-old man who has been…
read more here.
Keywords:
treatment tumour;
successful treatment;
osteomalacia resection;
induced osteomalacia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-249200
Abstract: Tumour-induced osteomalacia (TIO), also known as oncogenic osteomalacia, is an uncommon paraneoplastic syndrome which poses a diagnostic challenge. The hallmark feature is severe acquired hypophosphataemic osteomalacia due to renal phosphate wasting because of increased secretion…
read more here.
Keywords:
case tumour;
tumour induced;
induced osteomalacia;
challenging case ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-250237
Abstract: Tumour-induced osteomalacia (TIO) is a rare paraneoplastic syndrome. The constellation of findings of unprovoked fractures, hypophosphataemia, urinary phosphate wasting and a negative genetic evaluation suggest a TIO diagnosis. Tumours leading to TIO are often small…
read more here.
Keywords:
due residual;
induced osteomalacia;
osteomalacia due;
tumour induced ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-252412
Abstract: A man in his 40s was referred with persistent hypophosphataemia and bony pain. A serum fibroblast growth factor 23 level was markedly elevated and a diagnosis of tumour-induced osteomalacia was considered. Whole body imaging revealed…
read more here.
Keywords:
phosphaturic mesenchymal;
based intracranial;
tumour;
induced osteomalacia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "BMJ Case Reports"
DOI: 10.1136/bcr-2024-262528
Abstract: Tumour-induced osteomalacia (TIO) is an uncommon, debilitating disorder often characterised by non-specific clinical manifestations, posing a significant diagnostic challenge. The tumours causing TIO can be minuscule and occur in unusual areas, further complicating diagnosis. This…
read more here.
Keywords:
induced osteomalacia;
radiofrequency ablation;
tumour induced;
challenge ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "BMJ Case Reports"
DOI: 10.1136/bcr-2024-263622
Abstract: Phosphaturic mesenchymal tumours (PMTs) are rare neoplasms that secrete fibroblast growth factor 23 (FGF23), a hormone that disrupts phosphate homeostasis and induces tumour-induced osteomalacia (TIO). This condition causes hypophosphataemia, bone pain, fractures and musculoskeletal weakness.…
read more here.
Keywords:
phosphaturic mesenchymal;
tumour;
tumour induced;
due rare ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "BMJ Case Reports"
DOI: 10.1136/bcr-2024-263956
Abstract: Tumour-induced osteomalacia is a metabolic disorder that causes hypophosphataemia, resulting in bone mineralisation defects. If not treated definitively with tumour resection, this produces life-threatening anatomical changes. The anaesthetic management is tailored to address tumour location,…
read more here.
Keywords:
induced osteomalacia;
management patient;
tumour induced;
anaesthetic management ... See more keywords